CD274 and neoplasm: Promising prognostic and predictive factors in patients with mUC treated with ICIs include clinical features, new tumour molecular classes, the tumour mutational burden (TMB), mutational signatures, circulating tumour DNA (ctDNA) and programmed death-ligand 1 (PD-L1).